150 related articles for article (PubMed ID: 10698212)
1. Comparison of S-100 versus hematoxylin and eosin staining for evaluating dermal invasion and peripheral margins by desmoplastic malignant melanoma.
Eng W; Tschen JA
Am J Dermatopathol; 2000 Feb; 22(1):26-9. PubMed ID: 10698212
[TBL] [Abstract][Full Text] [Related]
2. Differences in tumor thickness between hematoxylin and eosin and Melan-A immunohistochemically stained primary cutaneous melanomas.
Drabeni M; Lopez-Vilaró L; Barranco C; Trevisan G; Gallardo F; Pujol RM
Am J Dermatopathol; 2013 Feb; 35(1):56-63. PubMed ID: 22688397
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical demonstration of S100 protein in malignant melanomas of the facial skin and oral cavity.
Korabiowska M; Mirecka J; Brinck U; Szuta M; Stypulkowska J; Wiese G; Bartkowski S; Schauer A
J Nihon Univ Sch Dent; 1994 Jun; 36(2):117-21. PubMed ID: 7521913
[TBL] [Abstract][Full Text] [Related]
4. [Application of sentinel lymph node biopsy in patients with melanoma].
Ren M; Kong YY; Cai X; Shen XX; Lyu JJ
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):360-365. PubMed ID: 29783803
[No Abstract] [Full Text] [Related]
5. Cutaneous melanoma with myxoid features: twelve cases with differential diagnosis.
Hitchcock MG; McCalmont TH; White WL
Am J Surg Pathol; 1999 Dec; 23(12):1506-13. PubMed ID: 10584704
[TBL] [Abstract][Full Text] [Related]
6. Selective lymph node dissection in patients with intermediate thickness melanoma: our experience.
Cafiero F; Peressini A; Percivale PL; Rainero ML; Faggioni M; Gipponi M; Queirolo P; Nicolo G; Bertoglio S
Anticancer Res; 2000; 20(1B):497-500. PubMed ID: 10769712
[TBL] [Abstract][Full Text] [Related]
7. Digital Quantification of Melanocytic Density in Resection Margins of Lentigo Maligna Using SOX10 Versus Hematoxylin-Eosin Staining.
Siarov J; Neittaanmäki N; Mölne J; Gillstedt M; Paoli J
Am J Dermatopathol; 2021 Apr; 43(4):273-277. PubMed ID: 32675472
[TBL] [Abstract][Full Text] [Related]
8. Utility of Multistep Protocols in the Analysis of Sentinel Lymph Nodes in Cutaneous Melanoma: An Assessment of 194 Cases.
Gill P; Howell J; Naugler C; Daoud MSA
Arch Pathol Lab Med; 2019 Sep; 143(9):1126-1130. PubMed ID: 30855172
[TBL] [Abstract][Full Text] [Related]
9. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
10. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Staining in the Assessment of Melanoma Tumor Thickness.
Kamyab-Hesary K; Ghanadan A; Balighi K; Mousavinia SF; Nasimi M
Pathol Oncol Res; 2020 Apr; 26(2):885-891. PubMed ID: 30875030
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymphadenectomy for staging patients with intermediate-level melanoma.
Smart KR; Cahoon BW; Dale PS
Am Surg; 2000 Mar; 66(3):280-3. PubMed ID: 10759200
[TBL] [Abstract][Full Text] [Related]
13. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
[TBL] [Abstract][Full Text] [Related]
14. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
Kanik AB; Yaar M; Bhawan J
J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
[TBL] [Abstract][Full Text] [Related]
15. Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.
Nielsen PS; Riber-Hansen R; Jensen TO; Schmidt H; Steiniche T
Mod Pathol; 2013 Mar; 26(3):404-13. PubMed ID: 23174936
[TBL] [Abstract][Full Text] [Related]
16. p75(NGFR) immunostaining for the detection of perineural invasion by cutaneous squamous cell carcinoma.
Lewis Kelso R; Colome-Grimmer MI; Uchida T; Wang HQ; Wagner RF
Dermatol Surg; 2006 Feb; 32(2):177-83. PubMed ID: 16442036
[TBL] [Abstract][Full Text] [Related]
17. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.
Anstey A; Cerio R; Ramnarain N; Orchard G; Smith N; Jones EW
Am J Dermatopathol; 1994 Feb; 16(1):14-22. PubMed ID: 7512798
[TBL] [Abstract][Full Text] [Related]
18. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study.
Longacre TA; Egbert BM; Rouse RV
Am J Surg Pathol; 1996 Dec; 20(12):1489-500. PubMed ID: 8944042
[TBL] [Abstract][Full Text] [Related]
19. Detection of mitotic figures in thin melanomas--immunohistochemistry does not replace the careful search for mitotic figures in hematoxylin-eosin stain.
Ottmann K; Tronnier M; Mitteldorf C
J Am Acad Dermatol; 2015 Oct; 73(4):637-44. PubMed ID: 26278815
[TBL] [Abstract][Full Text] [Related]
20. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
